Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)

NCT03639051 is registered in ClinicalTrials.gov with Nuvaira, Inc. as lead sponsor.

NCT NCT03639051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03639051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
Nuvaira, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 23, 2019
Completion date
September 30, 2028
Enrollment
464 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

copd